Effect of In Ovo Supplementation of Slab51 Probiotic Mixture, Associated with Marek’s Disease Vaccine, on Growth Performance, Intestinal Morphology and Eimeria spp. Infection in Broiler Chickens

Abstract

The interest for in ovo feeding has grown in the last decades mainly concerning probiotics, live microorganisms that can actively interact with the embryo. The aim of this study was to evaluate the effects of a multi-strain probiotic diluted in Marek’s disease vaccine (MDV) on zootechnical performances, intestinal morphology and Eimeria spp. infection. One hundred and twenty eggs of Ross 308 broiler chickens were incubated until 18 d, when 105 fertilised and vital eggs were randomly allocated into three groups. A control group (C) was inoculated with MDV; two treated groups (P1 and P2) were inoculated with MDV and different concentrations of probiotics: 1 × 105 CFU/100 μL in P1 and 1 × 106 CFU/100 μL in P2. After hatching, chickens were separated into three replicates (10/replicate). Zootechnical parameters were determined. At the end of the cycle (35 d), chickens were slaughtered, and the intestine was collected for morphological analysis from nine chickens per group (three/replicate). Eimeria spp. oocyst shedding was determined weekly, and parasitic lesions were analysed on the histological sample. In ovo treatment with probiotic did not influence hatching rate but significantly improved body weight and positively influenced intestinal morphometric data compared to C. Oocyst shedding in faeces resulted in an increase in C, with significant differences at sampling performed at 14, 21 and 28 d of age. These results suggest that the tested probiotic compound is safe for in ovo supplementation and effectively improves zootechnical performances and coccidian resistance.